MAPT and Alzheimer disease: Alzheimer's disease (AD) is associated with regional brain atrophy as well as elevated positron emission tomography (PET) markers of amyloid-beta (e.g., [18F]florbetapir (FBP)) and tau protein (e.g., [18F]flortaucipir (FTP).